OPTIMA MEDICAL INNOVATIONS CORP. Inactive Instrument
Optima Medical Innovations Corp. Stock Canadian Securities Exchange
Equities
TOKI
CA68405M1095
Pharmaceuticals
| Sales 2019 | 5.37M 7.35M | Sales 2020 | 4.61M 6.32M | Capitalization | 1.8M 2.46M |
|---|---|---|---|---|---|
| Net income 2019 | -17M -23.27M | Net income 2020 | -3M -4.11M | EV / Sales 2019 | 1.58 x |
| Net Debt 2019 | 2.19M 3M | Net Debt 2020 | 1.24M 1.7M | EV / Sales 2020 | 0.66 x |
| P/E ratio 2019 |
-0.35
x | P/E ratio 2020 |
-0.44
x | Employees | 9 |
| Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
Optima Medical Innovations Corp. is a Canada-based multidisciplinary pain management with the focus on mental health and wellness. The Company is focused on offering medicine in individualized and targeted treatments. It is also engaged in the development of focused solutions, products and treatments for pain relief, wellness, and cancer. The Company's consumer products include Miraqell Immune Mushroom, Miraqell Day Cream, Miraqell Cleanser and Miraqell Eye Serum.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +25.61% | 660B | |
| +25.87% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +7.09% | 219B | |
| -9.12% | 196B | |
| +5.01% | 199B | |
| -8.75% | 149B |
